Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib + FOLFIRI in mCRC
NCT00668863Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in colorectal cancer (CRC), sponsored by Pfizer. Primary endpoint: Progression-Free Survival. Started May 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00668863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668863.